Miguel López-Botet Selected Research

NK Cell Lectin-Like Receptor Subfamily C

3/2020	Adaptive NKG2C+ natural killer cells are related to exacerbations and nutritional abnormalities in COPD patients.
3/2015	Dynamics of the NK-cell subset redistribution induced by cytomegalovirus infection in preterm infants.
12/2013	NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus.
5/2013	Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction.
7/2006	Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miguel López-Botet Research Topics

Disease

18	Infections 05/2020 - 12/2004
9	Neoplasms (Cancer) 12/2021 - 04/2007
7	Cytomegalovirus Infections (Inclusion Disease) 10/2021 - 12/2004
4	Breast Neoplasms (Breast Cancer) 12/2021 - 01/2017
3	Virus Diseases (Viral Diseases) 01/2019 - 05/2010
3	Leukemia 01/2007 - 04/2002
2	Lymphocytosis 10/2021 - 03/2011
2	Multiple Sclerosis 05/2020 - 11/2010
2	Pathologic Complete Response 01/2019 - 01/2019
2	Viremia 01/2017 - 03/2015
2	Lymphoma (Lymphomas) 07/2005 - 10/2003
1	Prolymphocytic Leukemia 01/2020
1	Proteinuria 01/2019
1	T-Cell Leukemia (Leukemia, T Cell) 01/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2016
1	Inflammation (Inflammations) 11/2013
1	Stroke (Strokes) 11/2013
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2013
1	Vascular Diseases (Vascular Disease) 10/2011
1	Atherosclerosis 10/2011
1	Large Granular Lymphocytic Leukemia 03/2011
1	Carcinoma (Carcinomatosis) 05/2005
1	Myeloid Leukemia (Leukemia, Myelocytic) 12/2004

Drug/Important Bio-Agent (IBA)

7	Natural Killer Cell ReceptorsIBA 01/2017 - 12/2004
5	CytokinesIBA 05/2020 - 07/2005
5	NK Cell Lectin-Like Receptor Subfamily CIBA 03/2020 - 07/2006
4	KIR ReceptorsIBA 01/2020 - 12/2004
4	Leukocyte Immunoglobulin-like Receptor B1IBA 01/2020 - 10/2011
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 10/2011
3	Trastuzumab (Herceptin)FDA Link 12/2021 - 01/2017
3	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 05/2010
3	Antiviral Agents (Antivirals)IBA 01/2020 - 06/2010
3	AntibodiesIBA 01/2019 - 10/2011
3	Monoclonal AntibodiesIBA 04/2017 - 12/2004
3	LigandsIBA 05/2012 - 06/2010
2	AntigensIBA 01/2019 - 03/2011
1	Interleukin-2 (IL2)IBA 12/2021
1	Granzymes (Granzyme)IBA 12/2021
1	urelumabIBA 12/2021
1	HLA-G Antigens (HLA G)IBA 10/2021
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	CreatinineIBA 01/2019
1	human ERBB2 proteinIBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	LuciferasesIBA 01/2017
1	Estrogen ReceptorsIBA 01/2017
1	Dihydrotachysterol (AT 10)IBA 03/2015
1	C-Reactive ProteinIBA 11/2013
1	Pattern Recognition ReceptorsIBA 01/2013
1	Interleukin-6 (Interleukin 6)IBA 10/2011
1	Interleukin-10 (Interleukin 10)IBA 10/2011
1	Interleukin-12 (IL 12)IBA 10/2011
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2011
1	HLA-DRB1 Chains (HLA DRB1)IBA 03/2011
1	PerforinIBA 11/2010
1	NK Cell Lectin-Like Receptor Subfamily KIBA 06/2010
1	beta-N-AcetylhexosaminidasesIBA 01/2007
1	Interleukin-2 Receptor alpha SubunitIBA 07/2005
1	CalcineurinIBA 05/2005
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 05/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2004
1	EcdysoneIBA 10/2003
1	ecdysone receptorIBA 10/2003
1	Tyrosine (L-Tyrosine)FDA Link 04/2002
1	Serotonin (5 Hydroxytryptamine)IBA 04/2002

Therapy/Procedure

4	Immunotherapy 12/2021 - 04/2016
2	Kidney Transplantation 10/2021 - 01/2017
1	Therapeutics 01/2017
1	Organ Transplantation 01/2017